Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

Home
Infectious Disease
Metabolic
Neurological
Nutrition
Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

Home
Infectious Disease
Metabolic
Neurological
Nutrition
Public Health

Icotyde

FDA approves Icotyde psoriasis

March 25, 2026 Evan Vega

FDA Approves Icotyde (icotrokinra) for Moderate-to-Severe Plaque Psoriasis in Patients 12 and Older

The FDA approved ICOTYDE (icotrokinra) for treating moderate-to-severe plaque psoriasis in patients 12 and older weighing at least 40 kg.

Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.